Celularity Inc.

Anthrogenesis Corporation

Jodi P Gurney

Robert J Hariri

Uri Herzberg

Xiaokui Zhang

Wolfgang Hofgartner

Stacy Herb

Mohit B Bhatia

Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically effective amount of tissue culture plastic adherent placental stem cells (PDAC&#x2122;).

Treatment of pain using placental stem cells

Provided herein are methods of treatment comprising administering to a subject, e.g., a human subject, mononuclear cells from human placental perfusate and hematopoietic cells, and compositions comprising them, and their uses to establish chimerism, engraft tissue (e.g., blood), reduce the severity or duration of graft versus host disease, and treat or ameliorate symptoms of metabolic disorders and hematologic disorders, such as hematologic malignancies.

Therapy with cells from human placenta and hematopoietic cells

Provided herein are methods of treatment of an individual having amyotrophic lateral sclerosis, comprising administering to the individual a therapeutically effective amount of placental stem cells, e.g., tissue culture surface-adherent placental stem cells (PDACs). In one aspect, provided herein is a method of treating amyotrophic lateral sclerosis (ALS) comprising administering to an individual having ALS a therapeutically effective amount of placental stem cells. In certain embodiments, 'therapeutically effective' means an amount effective to reduce or ameliorate one or more symptoms of ALS.

Treatment of amyotrophic lateral sclerosis using placental stem cells

Growing community of inventors

Chicago, IL, United States of America

Jodi P Gurney